Drug Profile
Iseganan
Alternative Names: IB 367; IB 367-03; Iseganan hydrochloride; Iseganan oral rinse; Protegrin IB 367 RinseLatest Information Update: 28 Dec 2006
Price :
$50
*
At a glance
- Originator Ardea Biosciences
- Class Antibacterials; Antifungals; Peptide antibiotics; Protegrins
- Mechanism of Action Cell membrane modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Cystic fibrosis-associated respiratory tract infections; Mycoses; Stomatitis; Ventilator associated pneumonia
Most Recent Events
- 23 Jun 2004 Discontinued - Phase-II/III for Ventilator-associated-pneumonia (Prevention) in European Union (Buccal)
- 23 Jun 2004 Discontinued - Phase-II/III for Ventilator-associated-pneumonia (Prevention) in USA (Buccal)
- 23 Jun 2004 Clinical data from a media release have been added to the adverse events section